Arcellx (ACLX) EBT Margin (2023 - 2025)

Arcellx (ACLX) recorded quarterly EBT Margin of 3511.0% in Q4 2025, down 208.42% quarter-over-quarter from 1138.39% in Q3 2025, and down 321246.0% on a YoY basis from N/an in Q4 2024.

Arcellx (ACLX) EBT Margin (2023 - 2025) Analysis & Trends

Arcellx's EBT Margin history runs 3 years deep, the most recent figure standing at 3511.0% for Q4 2025.

  • In Q4 2025, EBT Margin fell 321246.0% year-over-year to 3511.0%; the TTM figure through Dec 2025 stood at 1027.08% (down 92955.0% YoY), while the FY2025 annual figure was 1026.95%, down 92941.0% from the prior year.
  • EBT Margin was 3511.0% for Q4 2025 at Arcellx, down from 1138.39% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 32.41% in Q4 2023 to a low of 3511.0% in Q4 2025.
  • Historically, EBT Margin has averaged 597.76% across 3 years, with a median of 215.9% in 2023.
  • The sharpest annual moves came in 2024 and 2025: EBT Margin soared 16452 bps in 2024, then tumbled 321246 bps in 2025.
  • A 3-year view of EBT Margin shows it stood at 32.41% in 2023, then plunged by 1021 bps to 298.55% in 2024, then tumbled by 1076 bps to 3511.0% in 2025.
  • The last three EBT Margin figures came in at 3511.0% (Q4 2025), 1138.39% (Q3 2025), and 693.97% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,511.00%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,511.00%
Sep 30, 2025 -1,138.39%
Jun 30, 2025 -693.97%
Mar 31, 2025 -766.02%
Dec 31, 2024 -298.55%
Sep 30, 2024 -98.52%
Jun 30, 2024 -98.09%
Mar 31, 2024 -18.34%
Dec 31, 2023 32.41%
Sep 30, 2023 -263.03%
Jun 30, 2023 -168.76%
Mar 31, 2023 -150.82%